Wave Eye Scouting 2020 Sip Club . . . Baiyang pharmaceutical pay steel: prescription drug marketing to the out-of-hospital terminal.

In 2020, consistency evaluation and collection will gradually become normal.
under the interweaving of the reform of the registration system, the system of drug listing license holders, and the acceleration of the inclusion of new drugs in the scope of medical insurance, pharmaceutical companies have begun to make transformation and upgrading through innovation, reorganization, mergers and acquisitions, etc., with a view to sustainable development.
in the new change of opportunity and challenge coexist, change is the key to landing on the beach.
In the main forum of the West Conference on August 13th, Fu Gang, chairman of Baiyang Pharmaceutical Group, mentioned in the keynote speech of "Integration and Innovation in the Symbica Age" that the pharmaceutical industry used to be divided into obvious upstream, midstream and downstream, but now the industrial structure is more refined, the competitive relationship is in the reconstruction stage, the ecological synergy is more and more abundant, so pharmaceutical companies need to work with their opponents to grow together.
he points out that "in an industry change, a shift in thinking from 'competitive logic' to 'symbient logic' is a smarter choice."
" Baiyang Pharmaceutical Group Chairman Fu Gang set to promote the original pattern of drugs and commercial value chain remodeling at present, with volume procurement has been carried out to the third batch.
the rules, there are 4 3, 6 4, there are 1.8 times the fuse mechanism and the 50% price reduction standard, the overall price reduction is very large.
in the pay steel, if the domestic drug in the collection of price reduction to 70 to 80%, most of the original pharmaceutical companies or choose to withdraw from participation.
for patients who have some capacity to pay, they may still want to use the original brand of medicine, especially those who have been using it for years.
if the hospital channels can not buy, patients may go to the retail side to buy.
a certain period of time, the brand value of the brand drug that has not been selected will be further released at the retail end.
Against the background of the expansion of the national drug collection and collection, the original pattern of drugs and the commercial value chain have been broken and remodeled, the share of the original research drug in the hospital market is gradually decreasing, and how the original research brand continues to release brand value in the retail market is a new challenge that pharmaceutical companies need to solve urgently.
the other side of the market, the impact of harvesting on the drug distribution industry is obvious.
hospitals as the main channel for the sale of prescription drugs, this function is rapidly weakening in the future.
, the main channel of drug sales is moving from hospitals to specialized pharmacies, especially Internet-based specialized pharmacies.
in the process of moving out of the hospital, the Internet will also get a big piece of the pie, the transfer to the fourth terminal is a huge channel change.
To the first half of this year, for example, the outbreak brought travel inconvenience, online prescription drug policy gradually liberalized, a large number of Internet hospitals, physical hospitals can prescribe prescription drugs, the first half of this year online prescription drug market showed geometric growth.
pointed out that the real and legal prescription online is the key guarantee for pharmacies to sell prescription drugs.
if the prescription is unreasonable or abnormal, it should be systematically regulated.
to the Internet professional pharmacy, Baiyang's third-party prescription transfer service platform "easy to re-diagnose" is involved.
third-party prescription transfer service platform has landed in 1 provincial platform, including Gansu Province, 6 municipal platforms and more than 300 hospitals, covering 100 million patients.
The platform essentially provides a regulatory platform for the Health and Safety Commission, a self-querying and informed service platform for patients, and an opportunity for pharmacies to provide convenient services to patients based on the platform.
professional commercialization platform to help prescription drug retailing China's pharmaceutical retail industry is accelerating differentiation, pharmacies rely on the traditional sale of small brands with high gross margin is difficult to grow on a large scale.
Not only is the original research brand medicine, Paygang introduced, they called prescription drug retailing OTX model, including the original research drug, consistent evaluation and Sino-US sales of three different grades, Baiyang according to their own professional standards of commercial platform, will help brand products in the retail market to reflect their own brand value.
At present, Mylan, Xi'an Yangsen, Takeda, Astellas, Jet Bellin, Sansheng Pharmaceuticals and other head pharmaceutical companies have reached a deep cooperation with Baiyang, with the help of Baiyang's commercial "highway", so that its high-quality products quickly layout to retail terminals, benefiting patients.
Pharmaceutical giants flocked to the market, the value is that Baiyang commercial platform for upstream industrial enterprises to provide a holistic solution, through completely channel management capabilities, multi-category synergy, digital marketing capabilities, in-depth study of linked medical institutions, retail enterprises and industrial enterprises, optimize marketing costs, improve marketing efficiency, to help the world's advanced medical technology and products from all channels to quickly enter the application scenario.
with the transfer of prescription drug marketing from the hospital to the professional out-of-hospital terminal, the pharmaceutical retail industry is gradually developing towards intensive and specialized direction.
, however, in the process of professional upgrading, the retail industry still has to face prescription to undertake, supply chain, pharmaceutical services and other professional competence challenges.
Said that by virtue of its strong industrial synergies, Baiyang to help pharmacies professional upgrade, efficiency improvement also has a unique advantage.
Baiyang and China Pharmaceutical Business Association, China Health Information and other industry institutions, authoritative experts to jointly develop professional pharmaceutical service training, to help pharmacies improve pharmaceutical service capabilities.
At the same time, Baiyang has long practiced the integration of the Internet and medicine, through its easy-to-re-diagnose third-party prescription transfer service platform to achieve three-doctor linkage, to ensure that the source of prescriptions in pharmacies legal traceability, through information tools, to help pharmacies to carry out customer asset management.
commercialization platform, terminal specialization upgrade these are different from the traditional marketing innovation behind, is Baiyang more than ten years of rich industrial accumulation and a deep understanding of the market.
With the development of drug-accompanied diagnostic and immunology technologies, Baiyang is willing to work with medical institutions, industrial enterprises and retail terminals to provide patient-centric health management solutions covering the entire life cycle of prevention, diagnosis, treatment and rehabilitation.
the future: Baiyang model harvest industry to respond positively to the "Health China" national strategy to achieve the landing, we must change the status quo of medical and health services fragmentation, the construction of a full-life health care services new ecology.
the theme of this session focuses on "full life cycle health management", which is in line with Baiyang's philosophy of building a healthy city complex.
days ago, qingdao International Health Industrialization Base core area, led by Qingdao City Key Planning, Baiyang, officially started construction, as China's first health city complex, it will integrate the global high-quality health care industry chain resources, China and the world health industry link window, domestic and foreign health enterprises layout of the Chinese market first stop.
" healthy city complex will become a new category of domestic health industry development, a new leap, not only the health industry and real estate development cross-border integration of innovation, but also integrated into qingdao city strategy.
With the park construction and Chinese the growing demand for health, the construction of a hundred billion-level health industrial park full of innovative vitality and humanistic atmosphere is also a long way to go, becoming a model for China and Qingdao business card.
" Fugang introduction, in addition to the layout of the industry, the complex will be built into a family with doctors, time care, often do physiotherapy, everyone understands health care professional health nursing home-level intelligent community.
In order to provide consumers with higher quality health products and more comprehensive services, in the evening of the 13th "Baiyang Night" theme dinner, Baiyang together with Takeda Pharmaceuticals, Astellas, Sansheng Pharmaceuticals, Ruiyu Pharmaceuticals, Green Valley Pharmaceuticals and other well-known pharmaceutical companies and chain enterprises, focusing on bone health, prostate, breasts, dry eyes, gnecation and other fields, jointly released "ten areas, ten health public welfare actions" to contribute to China's health industry.
based on the present, looking to the future, innovation, forward-looking "100-ocean model", symbigion win-win, integration and innovation of "hundred-ocean wisdom" in Sipu will become the focus of the industry.
Starting from the Sipu Association, Baiyang fusion innovation seizes policy and industry opportunities, is committed to bringing new industry solutions to upstream and downstream enterprises, so that every "day by day" with fearless courage, embrace the new era of health industry symbigion, see the health industry's changing trends and infinite possibilities.
.